Skip to main content
. 2020 Aug 4;25(6):503–507. doi: 10.1177/1074248420947628

Figure 4.

Figure 4.

Forest plot comparing mortality rates between patients with hypertension and concurrent COVID-19 infection who were receiving ACEIs or ARBs in a random effect model.